About:serfwerks

Posts by serfwerks :

RxCell Announces $4.6M Investment from DMR Global Venture and Regenosis, Plans for Second Raise of $15M for IND Testing in Q4 2023

Posted on by admin

SINGAPORE–(BUSINESS WIRE)–RxCell, a pioneering biotech company focusing on cellular therapeutics for age-related diseases, today proudly announces a $4,600,000 investment commitment from DMR Global Venture LLC and Regenosis. Building on the strength of collaboration with National University of Singapore, this fresh investment accentuates RxCell’s resolute drive to revolutionize age-related disease treatment. “We’re thrilled to align with […]

Read More

Culmination Bio Raises $10M From Amgen Ventures and Merck Global Health Innovation Fund to Bring Longitudinal Health Data to Biopharma

Posted on by admin

Culmination Bio has over 40 years of biospecimen data and counting, paired with clinical data from patient EHRs, making recruitment for pharmaceutical research almost instantaneous. St. George, Utah — (November 30, 2023) — Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health […]

Read More

SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK – ENROLLMENT TO STOP DUE TO SUCCESS

Posted on by admin

SALT LAKE CITY, Dec. 6, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the Data Safety Monitoring Board (DSMB) overseeing its pivotal Prematurity Risk Assessment Combined with Clinical Interventions for Improved Neonatal […]

Read More

2023 Utah Life Sciences Summit Recap and Gallery

Posted on by admin

BioUtah yesterday held its 2023 Utah Life Sciences Summit, presented by Mayer Brown. Every year, the Summit is the largest gathering of Utah’s life sciences industry. This year was no exception. Following welcome remarks from Gov. Spencer Cox, a distinguished line-up of top executives addressed a packed house. Keynote speaker, Joseph Smith, chief scientific officer […]

Read More

ATL Announces New VP of Human Resources

Posted on by admin

Springville, Utah, October 27, 2023—ATL Technology, a dynamic and rapidly expanding company specializing in medical device development and manufacturing, is thrilled to introduce Danelle Goulet as the new Vice President of Human Resources. Expressing her enthusiasm for her new role, Danelle shared, “I am excited by the challenge of a fast-growing company in the medical […]

Read More

BD Introduces Advanced Ultrasound Technology to Help Drive First-Stick Success for IV Insertions

Posted on by admin

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J. (April 11, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with […]

Read More

Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102

Posted on by admin

First-in-Human Study of Novel Oral Dual-Acting Antibody in Development for Treatment of Patients with Inflammatory Bowel Disease SALT LAKE CITY, UT, UNITED STATES, November 1, 2023 /EINPresswire.com/ — Sorriso Pharmaceuticals, a biopharmaceutical company developing novel oral antibodies in immune-mediated disease, today announced that the first subject has been dosed in the company’s Phase 1/1b clinical […]

Read More

BioUtah Announces New Board Leadership and Five New Board Members

Posted on by admin

SALT LAKE CITY – October 27, 2023 –BioUtah, Utah’s trade association serving the state’s life sciences community, announced today Myles Greenberg, MD, MBA, CEO of Alucent Biomedical, as the new board chair, effective January 2024. Dr. Greenberg, an experienced life sciences entrepreneur, venture investor, and board-certified emergency physician, succeeds Andrea Kendell, chief financial officer at […]

Read More

QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer

Posted on by admin

Partnership covers development of lab-developed and distributable kit-based companion diagnostic tests Combined strengths in assay development, clinical testing, and regulatory approvals offers pharma partners comprehensive global companion diagnostic solutions based on PCR, digital PCR (using the QIAcuity system), and NGS Future projects may include advanced analysis and accessibility of measurable residual disease (MRD) and homologous […]

Read More

Seek Labs Presents at the Animal Health, Nutrition & Technology Innovation Asia Summit in Tokyo, Japan

Posted on by admin

SALT LAKE CITY, UT, October, 18, 2023 – Seek Labs, a healthcare innovations company doing research in infectious disease diagnostic systems and pharmaceuticals, is pleased to announce its participation at the Animal Health, Nutrition & Technology Innovation Asia Summit in Tokyo, Japan. Craig Mosman, Chief Business Development Officer, was invited to speak on behalf of […]

Read More

DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells

Posted on by admin

Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding Salt Lake City, UT – October 18, 2023 – DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced a basic science Cooperative Research and […]

Read More